AmerisourceBergen Completes Acquisition of PharmaLex
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Acquisition advances role as a partner of choice for biopharmaceutical companies by enhancing global portfolio of specialty services
The acquisition of PharmaLex enhances AmerisourceBergen’s growth strategy by advancing its leadership in specialty services and global platform of pharma manufacturer services capabilities. PharmaLex’s regulatory affairs, development consulting and scientific affairs, pharmacovigilance, and quality management and compliance services expand AmerisourceBergen’s role as partner of choice for biopharmaceutical partners across the pharmaceutical development and commercialization journey.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20221231005019/en/
Investors:
610-727-3693
bmurphy@amerisourcebergen.com
Media:
215-460-6981
lesposito@amerisourcebergen.com
Source: